| Tag | Content |
|---|
EnhancerAtlas ID | HS026-10268 |
Organism | Homo sapiens |
Tissue/cell | CNCC |
Coordinate | chr14:51251620-51253670 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| YY1 | MA0095.2 | chr14:51251703-51251715 | CAAAATGGCTGC | + | 6.52 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_04332 | chr14:51251345-51252869 | Brain_Anterior_Caudate | | SE_09791 | chr14:51250080-51253289 | CD14 | | SE_11392 | chr14:51244894-51263382 | CD20 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH14I050784 | chr14 | 51251348 | 51260310 |
|
Enhancer Sequence | CTTCCTCATT ACTATGCCAG TGTACTGGCC AACAGCCCCA TTGAGAGTAG GCAGAGGGGA 60
GAAGGTCAGA GGTTGTCCGG CCCCAAAATG GCTGCTCACA AGACAGTCCC CAACCCCTCA 120
GGCAGACAAA AGGAGTCCCC CCAAACCCAC TCTGTGGGCC GTGCATCTCA ATGTCATGCT 180
GGCCATTGTA GCCAGCTCTT GAGTTGTCCT ACAGCTGGAC AAGGGTGCCC TGCACACAGC 240
GGCTGCACAG GCGGCACCGA TTTCTGGAAT GCTTTCTTTG GAGGGACACC TGCTTTGCTG 300
GACTGCAGAG CAGATGGCCA GAGCCTCCTG GATCTCCAGC TTCCAGCCCC AACGCCGGGC 360
CAGCATCTGC AGCCTGTGGT CCTGGTGTGG CCCCTGCCCA CAATAGCCCA GCCGCCACCC 420
CCACCAGCCA TCTGCTCCAG CGCAGACCTT TGCGCCCCGC AGAATGTACG GCTAATTAAA 480
ACCATTATGG GGGCAGACAC CGGGGCATTC TTACCCAGCA GAGGTTGCTG AGCTGATCTC 540
AGCAGCCTCA GAGCCTGGAG TAGAGTTGTG GTTTTTTGTT TTTGTTTTTG TTTTTTGGAA 600
AGGAAAAAGC CCTGTAAACC CAGAGAGAAG AGGAAGGAAA TGTACTAGAG TAACATAGCT 660
CCCCAAACAA ACTGAGCTGT AGTGTGCATT TAGAAGAGCA GCACATGTAG CTAAGCACAG 720
GAAGTCTCTG AAAACACCAG AAATCAGTTT AAGGAGAGTG CTCATGAAAG AAACTTTAAG 780
ACTTTTAAAA AATACAGCAT CTATGGCGTA TTTCACTAAC AGTCCTAAGT ATTTATAAAG 840
CCTGTGCTCT GAGCTGGGTA GTGGAAGCTG AGTGCGCCCG GCAGGGCTGG CTATTGTTTC 900
TGCAGGGACA CACTTCCTGG GACTGTGGTT CATTTTCCAC TATGCCACCT TTGAAGGCAA 960
AGGCAATGGA GAGCCTGACA GCCCAGCTCC CAGTCTCTCC ATTCTGAACT CCCGGACAAG 1020
CTCCTAAGGC CAGGGTTGTC ACGACCAGAA TGCAAATCAG TGCCTTTATC TTTAAAGGCA 1080
ATTAAGTGCT ACAAGTGCAT GCGGGGGATG ACAGGAATTA ACACGATTTT TAAACGCACA 1140
CACATTTAGA TGAGACCTGC TACACTGAAG GCTAAAAAAG CCTTTGGTAC TGCTGGTCCA 1200
AGGAAATGCT GAATTTAAGA GTTTGGGCCT TAAGCCTCTT CTCCTACCAA GGCTGGGGAC 1260
TAGTTTTGGT TCACTGGATT TTAAAGTCCT TAAAGGAAAG AGATTTTAAA AAATACCTTT 1320
CCTGCTCCTC AGAGCTGCTA AGTAACGAAT ACTACTTTTC TGTTGGAAAA TATTTAATGA 1380
TATGTAGGAC AGAAAATGTT ACTGTCATCA TGAACATTAA TTCTTGACTT CTTGTCTGTT 1440
TTAGTTTCTA GTTAGAAGAT AAATATTAGA AATTGTTGAT CTGGAAGGAG GTGGGGGTGG 1500
GGTCTGGTCT CCAAGACAAT TCCCGCTGGG ATCAAGTCAG GAAGGCTCAC CAGGACACTA 1560
AAGCCTAAAA GTATGTGTCA GAAAAAGAGA CATTTTATAA GCTTTGAAGG AGCTTCTTTC 1620
TATCACTTTC AAGTGATCTA CAATTGCATC TTTAATGAAT GTTTCATCTC TGGGAATAGC 1680
CGGATGATCT GATAAGACTT AAGACAATGA AGGAAAAGAA TGGAATTCCA TTAAAAAAAA 1740
AAAAGTCCAT CCTGAAGACA TCATAGCCTT TGGTAGAATA AATGGCATCA GCAATAAAAC 1800
TGTTTGCTTT GTCAAAGACT GGAACAGAAA ATTTAACAAG GGAGTAACAG GAAAATAGGT 1860
GCATTTCAGC TACAAAAGAT CTTAGCAGAA CTTCTCTTGG TTATTAAGTT TACTCCAGAA 1920
TTAAATATTG ACTCTGTACG ATGTAAATGA ATAATTCATA AACTGCAAAG TTATGCATAC 1980
ATGAAAATGA ACATAAGGGA AAAGATAAGT CAGTTTCACA CTTCTTGAAG AAGTTTCATT 2040
TTATGTAGGG 2050
|
